SPECT Radiopharmaceuticals with Marketing Authorization

Radionuclide Generator ⁸¹Rb/^81mKr

• half-life of the ^81mKr is 13.1 s, gamma emission energy is 190.4 keV
• a radiopharmaceutical for the investigation of the ventilation of the lungs (pulmonary embolism, chronic obstruction disease, chronic bronchitis, asthma and bronchogenic carcinoma)
• reliable imaging of the real state of the ventilation of the lungs thanks to elimination of the false-negative results (the passive ventilation of the lungs)
• low irradiation exposure of the pacient and the absence of the radioactive waste
• difference of the emitted gamma quantum of ^81mKr (190.4 keV) and ^99mTc (140.5 keV) enables a parallel investigation of the ventilation of the lungs using inhalation and perfusion which are the best diagnostic tools for pulmonary embolism